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Abstract
This paper focuses on the derivation and simulation of mathematical models describing new plasma fraction
in blood for patients undergoing simultaneous extracorporeal membrane oxygenation and therapeutic plasma
exchange. Models for plasma exchange with either veno–arterial or veno–venous extracorporeal membrane
oxygenation are considered. Two classes of models are derived for each case, one in the form of an algebraic
delay equation and another in the form of a system of delay differential equations. In special cases, our models
reduce to single compartment ones for plasma exchange that have been validated with experimental data [15]. We
also show that the algebraic delay equations are forward Euler discretizations of the delay differential equations,
with timesteps equal to transit times through model compartments. Numerical simulations are performed to
compare different model types, to investigate the impact of plasma device port switching on the efficiency of the
exchange process, and to study the sensitivity of the models to their parameters.
1 Introduction
Therapeutic Plasma Exchange (TPE) refers to the removal and possible exchange of a patient’s blood plasma.
This procedure treats a variety of conditions, from renal diseases to neurological disorders [11, 2]. It has very
recently received attention as a possible therapy for COVID–19 [9, 7, 4]. TPE is typically done by connecting
the patient’s circulation to a device that slowly draws in blood, separates out old plasma, adds in new plasma or
some other replacement fluid, and puts this mixture back into the native circulation. Extracorporeal Membrane
Oxygenation (ECMO) is a procedure used for reoxygenating blood with an external circuit. There are two main
types of ECMO, veno–venous and veno–arterial, and they are distinguished from each other by the placement
locations of the inlet and return lines within the patient’s circulation [13]. Veno–venous ECMO draws from and
replaces blood within the venous circulation. It is traditionally used when the patient’s heart is functioning well
enough to perfuse their organs. Veno–arterial ECMO bypasses both the heart and lungs and is used in cases
where the patient needs both reoxygenation and circulatory support. In this case, blood is drawn from the veins
and re–enters the native circulation through the arteries.
The clinical scenario of interest in this paper is simultaneous ECMO and plasma exchange, which is usually
done by connecting the TPE device directly to the ECMO circuit, often at the ECMO inlet line [3, 5, 10]. This
technique has been used to treat conditions such as multisystem organ failure or the rejection of a transplanted
organ [6, 3, 5]. There are multiple parameters that affect the plasma exchange procedure in these cases, including
inlet and return flow rates for the ECMO and TPE devices, fraction of native cardiac output supported by the
ECMO circuit, and recirculation of new plasma. This paper develops mathematical models that help quantify
the impact of these parameters on plasma exchange done with ECMO. We derive two classes of models that each
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describe fraction of new plasma over time, and we consider both veno–venous and veno–arterial ECMO. The
approaches used in this paper can be applied to other apheresis techniques done in conjunction with ECMO.
To our knowledge, there are no mathematical models for simulating simultaneous ECMO and plasma ex-
change besides our previous work [14]. This paper provides mathematical justification for our previous model,
extends this approach to both veno–arterial and veno–venous ECMO, and derives a new class of related models.
There has been some research focused on separately modeling either plasma exchange or ECMO procedures.
A compartmental model of plasma exchange kinetics was described by Kellogg and Hester [8]. They derived
equations for plasma concentrations in both the intra– and extra–vascular spaces. A single compartment model
for plasma exchange was proposed by Randerson et al. [15]. Our approach is similar to the models introduced
in these papers in that it describes plasma kinetics through several distinguished compartments, but our focus
is on the interaction between the heart/lung, peripheral, and ECMO compartments. When these compartments
are lumped together, we show that our model reduces to that of Randerson et al. [15]. Our approach is also able
to describe possible recirculation of new plasma through these various spaces. As far as simulations for ECMO
procedures, we mention the work by Zanella et al., which focuses on oxygenation in veno–venous ECMO [17].
This paper provides derivations for the two classes of models: algebraic delay equations and systems of delay
differential equations. We also consider two possible configurations for the TPE device, either “typical” and
“switched.” These configurations refer to the orientation of the TPE device ports with respect to the ECMO
device flow direction. In the typical configuration, the inlet line for the TPE device is upstream from the return
line, and in the switched configuration these lines are reversed. A comparison of these two configurations was
the focus of our initial modeling effort, and we further study these two configurations in this paper [14]. We also
present numerical results comparing different classes of models and different configurations of the TPE device.
2 Mathematical model descriptions
Our approach is to divide the system consisting of the patient, ECMO circuit, and TPE device into three
compartments: (1) the heart and lungs; (2) the peripheral organs; and (3) the ECMO circuit with the attached
TPE device. Each compartment has an associated volume and flow rate of blood. The ratio of of volume to
flow determines the transit time of a parcel of new plasma through the given compartment. In particular, fixing
two of the parameters for a given compartment (transit time, flow, or volume) will determine the third. Flows
through compartments will always be specified, and either transit times or volumes will be given, depending
on available data. Models are derived in this section for the typical and switched configurations in the cases of
veno–arterial and veno–venous ECMO with therapeutic plasma exchange.
In these models, Q is the volume of blood per unit time flowing through the peripheral compartment. The
parameter α is defined so the product αQ is the flow through the ECMO compartment and by the TPE device.
The parameter Q1 is the flow into and out of the TPE machine, which is typically much smaller than Q. In all
cases, we assume the following constraints on α:
Q1 < αQ < Q. (1)
See Figure 1. These inequalities ensure that the flow into the TPE device does not exceed the flow going by
it, and that the ECMO device contributes a fraction α of the total cardiac output Q through the peripheral
compartment. Define the parameter [P ]0 to be the volumetric concentration of total plasma (both new and old
plasma) in blood, i.e. volume of plasma per volume of blood. We assume [P ]0 to be constant during the plasma
exchange process, and although it does not explicitly appear in the model equations, we use it for book keeping
purposes in the derivation. The parameters s1, s2, and s3 are transit times through the heart/lung, peripheral,
and ECMO compartments, respectively. In practice, there are distributions of possible transit times, so these
parameters can be interpreted as averages of these distributions. An interesting potential extension for these
models would be to incorporate in some way the transit time distributions. The compartment blood volumes
are V1, V2, and V3. Volumes and transit times are related by the blood flow through each compartment, and
these equations will be different in the cases of veno–arterial and veno–venous ECMO.
Referring to Figure 1, the variables of interest are γ1(t) and γ2(t), the fractions of new plasma in blood down-
stream from the heart/lung and peripheral compartments, respectively. Other auxiliary variables for fraction
of new plasma in different locations of the models are used in the derivations and will be defined in context.
We make two important simplifying assumptions that are used in the model derivation for each case. First,
we assume old plasma is completely exchanged for new plasma, implying volume of old plasma per unit time
flowing into the device and volume of new plasma per unit time flowing out of the device is Q1[P ]0. Second, we
assume old and new plasma are instantaneously mixed at junctions. Under these assumptions, conservation of
new plasma at junction A in Figures 1 and 2 is:
junction A : (αQ−Q1) γ2(t− s3) [P ]0 +Q1 [P ]0 = αQ γ˜(t) [P ]0, (2)
in which γ˜(t) is the fraction of new plasma directly downstream from the TPE device at time t. The first term in
equation (2) also incorporates the transit time s3 through the ECMO compartment as a delay. From this point
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forward, the model derivations for veno–arterial and veno–venous ECMO are different and will be described in
the following two subsections.
2.1 The typical configuration for veno–arterial ECMO
heart/lung
peripheral
ECMO
TPE
γ2
γ1
γˆ
γ˜
Q− αQ
αQ
Q
Q1Q1
A
B
Figure 1: The typical configuration for veno–arterial ECMO with therapeutic plasma exchange.
For the model of veno–arterial ECMO with TPE, as shown in Figure 1, conservation of new plasma at junction
B is
junction B : αQ γ˜(t) [P ]0 + (Q− αQ) γ1(t) [P ]0 = Q γˆ(t) [P ]0, (3)
where γˆ(t) is the fraction of new plasma directly upstream from the body compartment. The transit times and
volumes of the different compartments are related by the blood flows through each:
s1 =
V1
Q− αQ, s2 =
V2
Q
, s3 =
V3
αQ
.
Two different models will be derived. The first model considers the change in volume of new plasma per unit
time in the heart/lung and peripheral compartments:
d
dt
(V1γ1) = (Q− αQ) γ2(t)− (Q− αQ) γ1(t),
d
dt
(V2γ2) = Q γˆ(t)−Qγ2(t).
Using equations (2) and (3), we can rewrite these equations as a system of delay differential equations:
DDE model: typical configuration of VA ECMO with TPE
d
dt
(V1γ1) = (Q− αQ) γ2(t)− (Q− αQ) γ1(t),
d
dt
(V2γ2) = (Q− αQ) γ1(t) +Q1 + (αQ−Q1) γ2(t− s3)−Qγ2(t),
(4)
which is our first model for the typical configuration of VA ECMO with TPE. An alternative model takes the
form of an algebraic delay equation. It is derived from equations (2)–(3) along with the following relationships
between new plasma fractions at different locations and the transit times as delays:
γ1(t+ s1) = γ2(t) and γ2(t+ s2) = γˆ(t).
After algebraic manipulation, the equation for fraction of new plasma downstream from the heart/lung com-
partment is:
3
ADE model: typical configuration of VA ECMO with TPE
γ1(t) =
Q1
Q
(
1− γ1(t− s2 − s3)
)
+ αγ1(t− s2 − s3) + (1− α) γ1(t− s1 − s2).
(5)
2.2 The typical configuration for veno–venous ECMO
heart/lung
peripheral
ECMO
TPE
γˆγ1
γ2
γ˜
Q
αQ
Q
Q1Q1
A
B
Q− αQ
Figure 2: Typical configuration for veno–venous ECMO with therapeutic plasma exchange.
Figure 2 depicts our model for veno–venous ECMO with TPE. As in the previous section, we write down a
statement for conservation of new plasma at junction B in Figure 2.
junction B : αQ γ˜(t) [P ]0 + (Q− αQ) γ2(t) [P ]0 = Q γˆ(t) [P ]0. (6)
In this case, γˆ(t) is the fraction of new plasma upstream from the heart/lung compartment. As before, the
transit times through the different compartments are deteremined by their volumes and corresponding flows:
s1 =
V1
Q
, s2 =
V2
Q
, s3 =
V3
αQ
.
Conservation of new plasma through the peripheral and heart/lung compartments can be written in differential
equation form as:
d
dt
(V1γ1) = Q γˆ(t)−Qγ1(t),
d
dt
(V2γ2) = Qγ1(t)−Qγ2(t).
Using equations (2) and (6) we obtain a delay differential equation model:
DDE model: typical configuration of VV ECMO with TPE
d
dt
(V1γ1) = (Q− αQ) γ2(t) +Q1 + (αQ−Q1) γ2(t− s3)−Qγ1(t),
d
dt
(V2γ2) = Qγ1(t)−Qγ2(t).
(7)
An algebraic delay equation can also be derived for this configuration, using the following relationships
between the transit times and new plasma fractions at different locations:
γ1(t+ s1) = γˆ(t) and γ2(t+ s2) = γ1(t).
4
After algebraic manipulation we obtain:
ADE model: typical configuration of VV ECMO with TPE
γ1(t) =
Q1
Q
(
1− γ1(t− s1 − s2 − s3)
)
+ αγ1(t− s1 − s2 − s3) + (1− α)γ1(t− s1 − s2).
(8)
In this case, the nonzero delay time s3 for the ECMO compartment makes the models above much more
interesting. If transport through the ECMO compartment occurs infinitely fast, i.e. s3 = 0, both models (7)
and (8) lose their dependence on α.
2.3 Models for port switching within the plasma exchange device
heart/lung
peripheral
ECMO
TPE
γ2
γ1
γˆ
γ˜
Q− αQ
αQ
Q
Q1Q1
A
B
Figure 3: The switched configuration for veno–arterial ECMO with therapeutic plasma exchange.
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γ2
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Q
αQ
Q
Q1Q1
A
B
Q− αQ
Figure 4: The switched configuration for veno–venous ECMO with therapeutic plasma exchange.
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An application of this modeling approach will be the study of TPE device port switching on the efficiency of
the plasma exchange process. Figures 3 and 4 depict schematics for VA and VV ECMO in which the inflow and
outflow ports of the TPE device have been reversed from their typical configuration. In this case, the inflow
port is downstream from the outflow port, causing some recirculation of new plasma through the TPE device.
The models for this scenario can be derived in the same way as for the typical configurations. For veno–arterial
ECMO with TPE, we have the following delay differential equation model:
DDE model: switched configuration of VA ECMO with TPE
d
dt
(V1γ1) = (Q− αQ) γ2(t)− (Q− αQ) γ1(t),
d
dt
(V2γ2) = (Q− αQ) γ1(t) + αQQ1
Q1 + αQ
+
α2Q2
Q1 + αQ
γ2(t− s3)−Qγ2(t).
(9)
The algebraic delay equation model in this case is
ADE model: switched configuration of VA ECMO with TPE
γ1(t) =
αQ1
Q1 + αQ
(
1− γ1(t− s2 − s3)
)
+ αγ1(t− s2 − s3) + (1− α) γ1(t− s1 − s2).
(10)
For veno–venous ECMO with TPE and the switched configuration for the ports, we have the following delay
differential equation model:
DDE model: switched configuration of VV ECMO with TPE
d
dt
(V1γ1) = (Q− αQ) γ2(t) + αQQ1
Q1 + αQ
+
α2Q2
Q1 + αQ
γ2(t− s3)−Qγ1(t),
d
dt
(V2γ2) = Qγ1(t)−Qγ2(t).
(11)
The algebraic delay equation model for this case is:
ADE model: switched configuration of VV ECMO with TPE
γ1(t) =
αQ1
Q1 + αQ
(
1− γ1(t− s1 − s2 − s3)
)
+ αγ1(t− s1 − s2 − s3) + (1− α)γ1(t− s1 − s2).
(12)
Remark 1. Consider a special case for the models of VV ECMO with TPE in which the heart/lung and peripheral
compartments are treated as a single compartment. In this case, assume the fractions of new plasma downstream
from each of these compartments are the same:
γ1(t) = γ2(t).
Also, assume the transit time through the ECMO compartment is zero, corresponding to s3 = 0. These assump-
tions formally convert our model to the single compartment one for plasma exchange of Randerson et al. [15].
Note that the DDE and ADE models for the typical configuration of VV ECMO with TPE do not depend on
α. Interestingly, for the switched configuration, the models still depend on α. The DDE models for the typical
and switched configurations for VV ECMO with TPE take the simplified form:
d
dt
γ2 =
β
V1 + V2
(1− γ2(t)) , (13)
where for the typical configuration we have β = Q1 and for the switched configuration we have β =
αQQ1
αQ+Q1
.
Equation (13) for γ2 has an analytical solution of the form:
γ2(t) = 1− exp
(
− β t
V1 + V2
)
.
For the typical configuration, this equation can be rewritten as:
1− γ2(t) = exp
(
− Q1[P ]0 t
(V1 + V2)[P ]0
)
. (14)
6
The term 1− γ2(t) is the fraction of old plasma downstream from the heart/lung and peripheral compartments,
at time t. The term Q1[P ]0 t is the volume of plasma processed up to time t, since Q1 is the TPE device flow,
and (V1 + V2)[P ]0 is the total volume of plasma, both new and old, within the native circulation (i.e. the sum
of volumes in the heart/lung and peripheral compartments). The ratio of these two terms appearing in the
exponential of (14) can be interpreted as the number of plasma volumes processed, corresponding to a multiple
of the total volume of plasma contained in the native circulation. In words, equation (14) is:
typical configuration
(
fraction of old
plasma remaining
)
= exp (−plasma volumes processed) , (15)
which is one of the “informal laws of apheresis.” Equation (15) is the same as that obtained in the single
compartment model derived by Randerson et al. [15], with the seiving coefficient of the plasma exchange device
equal to 1. This is significant since their model of plasma exchange was validated with clinical data. The
analogous equation for the switched configuration is:
switched configuration
(
fraction of old
plasma remaining
)
= exp
(
− αQ
αQ+Q1
× plasma volumes processed
)
. (16)
Equation (16) is slight modification of (15) and accounts for port switching in the plasma exchange device; it
includes the term αQ
αQ+Q1
that multiplies the number of plasma volumes. Practically, the TPE device flow Q1
is small relative to αQ, so the ratio αQ
αQ+Q1
≈ 1 and the typical and switched configurations have roughly the
same plasma exchange efficiency. As we shall show in our numerical results, the switched configuration is much
less efficient in the regime αQ ≈ Q1.
Remark 2. The algebraic delay equations can be derived from the delay differential equations by replacing the
time derivative with an approximate difference quotient. In particular, the difference quotient
d
dt
(Viγi) ≈ Vi
si
(γi(t+ si)− γi(t)) , i = 1, 2, (17)
used in the DDE model, combined with the relationships between the flows, volumes, and transit times, results
in the corresponding ADE model. As an example, equation (4) with approximation (17) becomes
V1
s1
(γ1(t+ s1)− γ1(t)) = (Q− αQ) γ2(t)− (Q− αQ) γ1(t), (18)
V2
s2
(γ2(t+ s2)− γ2(t)) = (Q− αQ) γ1(t) +Q1 + (αQ−Q1) γ2(t− s3)−Qγ2(t). (19)
Using (Q−αQ) s1 = V1 in equation (18), we obtain the delay relation used to derive the algebraic delay equation,
namely:
γ1(t+ s1) = γ2(t).
The algebraic delay equation (5) for this case follows from the above equation along with (19) and Qs2 = V2.
Similar arguments can be made for the other configurations.
In this way, the ADE models can be interpreted as forward Euler discretizations of the DDE models, with
timesteps equal to compartment transit times. Depending on the clinical scenario, plasma exchange may be done
multiple times, and each exchange procedure happens over the course of hours. The time scale of this process
is slow in comparison to transit times through various compartments of the body. For example, if the volume
of blood is 5 liters and the corresponding cardiac output is 5 liters/minute, the transit time of a red blood cell
through the entire circulation can be approximated as the ratio of the volume to the flow, i.e. 60 seconds. This
separation of time scales reveals that the ADE and DDE models provide results very close to each other with a
difference on the order of max(s1, s2).
3 Results
In this section, we describe some results from numerical simulations of our models for veno–arterial and veno–
venous ECMO with plasma exchange. First, we compare the algebraic delay equations and delay differential
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equations. Second, we use these models to quantify the differences between the typical and switched configura-
tions of the plasma exchange device. Third, we perform an analysis of the sensitivity of these models to their
parameters. In our simulations, the timestep size is chosen to be ∆t = 10−2 seconds. The transit times s1, s2,
and s3 are chosen in a manner to be described below based on parameters and other available data, but are
selected to be the closest multiple of the timestep size for ease in simulating the models. The delay differential
equations are discretized with the forward Euler method.
3.1 Comparing algebraic delay and delay differential equation models
First, we compare the ADE and DDE models for each configuration. Nominal parameters are chosen as follows.
The flow Q is set to 116.7 mL/second [16]. Transit times through the peripheral and heart/lung compartments
are chosen to be s1 = 13 seconds and s2 = 39 seconds, following estimations of compartment volumes in Weiss
and Neimann et al. [16, 12]. We assume the ECMO circuit maintains 70% of the flow through the peripheral
compartment corresponding to α = 0.7. The transit time through the ECMO compartment is determined by
s3 =
V3
αQ
, where the ECMO blood volume V3 is chosen to be 500 mL [1, 6]. The TPE device flow Q1 is set to
1.5 mL/second [5]. Initial conditions for fractions of new plasma are γ1(t) = γ2(t) = 0 for 0 ≤ t ≤ s1 + s2 + s3.
Figure 5 shows a comparison of the ADE and DDE models for VA ECMO. The new plasma fraction down-
stream from the heart/lung compartment, γ1(t), is plotted for each case. Results for the typical configuration of
the plasma exchange device are on the left and results for the switched configuration are on the right. Figure 6
shows the corresponding results for VV ECMO. In both sets of figures we included an inset figure which depicts
a small subinterval of time to show the small differences between the ADE and DDE models. Following Remark
2, the two types of models are very close to each other since the compartment transit times are on the order
of minutes, and the plasma exchange procedure is simulated over the course of multiple hours. We also remark
that the inset figures show some small differences between the typical and switched configurations. The switched
configuration is less efficient since the fraction of new plasma at a given time is smaller than in the typical
configuration. We further investigate these differences in the next subsection.
0 1 2 3
0
0.5
1
1.39 1.395 1.4
0.74
0.745
0 1 2 3
0
0.5
1
1.39 1.395 1.4
0.735
0.74
Figure 5: A comparison of the ADE (black) and DDE (red) models for VA ECMO with TPE, for the typical
configuration of the TPE on the left, and the switched configuration on the right. The inset figure shows a zoomed
in portion of the results.
3.2 The effect of port switching on plasma exchange
In this subsection, we use our models to compare the typical and switched configurations for the TPE device
ports. In the switched configuration, the return line for the TPE device is upstream from the inlet line. This
setup leads to recirculation of new plasma, meaning that some new plasma entering the ECMO circuit through
the return line is immediately processed by the TPE device. The switched configuration is not an ideal setup for
plasma exchange, but our calculations in Remark 2 and simulations from the previous subsection suggest that
it results in very similar plasma exchange efficiency for a nominal choice of parameters. As also suggested in
Remark 2, the switched configuration may be much less efficient when the fraction α of cardiac output supported
by the ECMO device is very small.
Figures 7 and 8 depict results from our models with smaller values of α and provide a comparison of the typical
and switched configurations. Simulations are done with the DDE models and the same nominal parameters as in
the previous section. In the left panel of these figures, we show new plasma fraction curves for both configurations
and for the smallest value of α considered. The switched configuration for the cases of VA and VV ECMO is
much less efficient in exchanging plasma than the typical configuration. The right panel shows percent differences
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Figure 6: A comparison of the ADE (black) and DDE (red) models for VV ECMO with TPE, for the typical
configuration of the TPE on the left, and the switched configuration on the right. The inset figure shows a zoomed
in portion of the results.
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Figure 7: Results for VA ECMO: the left panel shows fraction of new plasma for a small value of α for both the
typical and switched configurations. The right panel shows the percent difference in fraction of new plasma between
these two configurations for several values of α.
between these configurations for different values of α. Notice that as α grows, both configurations maintain
essentially the same plasma exchange efficiency.
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Figure 8: Results for VV ECMO: the left panel shows fraction of new plasma for a small value of α for both the
typical and switched configurations. The right panel shows the percent difference in fraction of new plasma between
these two configurations for several values of α.
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3.3 Sensitivity analysis
This subsection describes a study of the sensitivity of the fraction of new plasma to changes in the parameters
of the model. We define the sensitivity for a parameter Y ∈ {Q1, Q, α, s1, s2, V3} as the partial derivative of γ1
with respect to Y , evaluated at t = 4 hours. The sensitivity is approximated as:
∂γ1
∂Y
∣∣∣
t=4 hours
≈ γ1(t, Y˜ )− γ1(t, Y )
Y˜ − Y
∣∣∣
t=4 hours
,
in which Y is taken to be the nominal value of the parameter used in subsection 3.1, and Y˜ = 1.1 × Y , i.e.
ten percent larger than the nominal value. In other words, our approximation to the sensitivity is a forward
difference approximation to the partial derivative. For the calculations in this section, the ADE models for both
the typical and switched configuration are used.
0.00 0.02 0.04 0.06 -0.0015 -0.0010 -0.0005 0.0000
Sensitivities for VA ECMO – typical config. – ADE model
Figure 9: Sensitivities for VA ECMO with the typical configuration of the TPE device. The left panel shows all of
the sensitivities, and the right panel shows the four smallest sensitivities.
0.00 0.02 0.04 0.06 -0.0015 -0.0010 -0.0005 0.0000
Sensitivities for VA ECMO – switched config. – ADE model
Figure 10: Sensitivities for VA ECMO with the switched configuration of the TPE device. The left panel shows all
of the sensitivities, and the right panel shows the four smallest sensitivities.
Figures 9 and 10 show sensitivities for the models of VA ECMO and for the typical and switched configurations
of the TPE device, respectively. Figures 11 and 12 show the same results but for VV ECMO with TPE. The
left panel of these figures shows results for all of the parameters, and the right panel shows results for the four
parameters with the smallest sensitivity in each case. The results reveal that for both types of ECMO and for
the typical and switched configurations of the TPE device, Q1 has the largest impact on the fraction of new
plasma. Further, the TPE device flow is directly related to fraction of new plasma: an increase in Q1 leads to an
increase in new plasma fraction. Another feature common across ECMO types and TPE device configurations
is the lack of sensitivity with respect to the ECMO compartment volume V3. Also, the fraction of new plasma
is inversely related to V3, meaning that a larger extracoporeal volume results in less efficient plasma exchange.
One puzzling aspect is the sensitivity of the models to the fraction α of cardiac output Q supported by
the ECMO circuit. For VA ECMO and both TPE device configurations, an increase in α, corresponding to an
increase in ECMO circuit flow and hence flow by the TPE device, leads to an increase in the fraction of new
plasma. This result is also seen for VV ECMO and the switched configuration of the TPE device. Surprisingly,
the opposite result is seen for VV ECMO with the typical configuration of the TPE device: an increase in ECMO
circuit flow results in very small drop in fraction of new plasma.
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Sensitivities for VV ECMO – typical config. – ADE model
Figure 11: Sensitivities for VV ECMO with the typical configuration of the TPE device. The left panel shows all
of the sensitivities, and the right panel shows the four smallest sensitivities.
0.00 0.05 0.10 -0.0020 -0.0010 0.0000
Sensitivities for VV ECMO – switched config. – ADE model
Figure 12: Sensitivities for VV ECMO with the switched configuration of the TPE device. The left panel shows all
of the sensitivities, and the right panel shows the four smallest sensitivities.
4 Conclusions
In this paper, we derived models for therapeutic plasma exchange done simultaneously with either veno–venous
or veno–arterial extracorporeal membrane oxygentation. These models describe fraction of new plasma in blood
over time. Two types of models were developed: algebraic delay equations and systems of delay differential
equations. We showed that our models in special cases reduce to the one described by Randerson et al. [15],
which is important because their model was validated with clinical data. Our models extend their work by
incorporating separate compartments for the native circulation and the ECMO device, and our models also
account for recirculation of new plasma. We showed that the algebraic delay equations are forward Euler
discretizations of the delay differential equations, with timesteps equal to compartment transit times. These
transit times are small compared to the plasma exchange procedure, so the algebraic delay equations and systems
of delay differential equation gave very similar results. Our models were applied to the scenario of port switching
in the plasma exchange device, and our numerical results demonstrated that the switched configuration is less
efficient in our models in exchanging plasma when the ECMO flow is very small. Sensitivity analysis revealed
the models are most sensitive to TPE device flow and least sensitive to ECMO circuit volume.
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